肠道菌群与2型糖尿病微血管病变的研究进展
Research Progress of Intestinal Flora and Type 2 Diabetes Mellitus Microangiopathy
DOI: 10.12677/ACM.2022.126768, PDF,    科研立项经费支持
作者: 马明福, 陈映存, 王 丽, 丁 娟, 张世清, 李玉英：青海省第五人民医院(青海省肿瘤医院)内分泌科，青海 西宁
关键词: 肠道菌群；2型糖尿病；糖尿病微血管病变；视网膜病变；神经病变；肾脏病变；Intestinal Flora； Type 2 Diabetes Mellitus； Diabetic Microangiopathy； Retinopathy； Neuropathy； Re-nal Lesion
摘要: 2型糖尿病(Type 2 diabetes mellitus ,T2DM)仍然是威胁全人类健康及造成人们经济负担的最主要问题之一，其患病率和发病率呈逐渐增加的趋势。同时糖尿病也是导致失明、肾衰竭、心脏病发作、中风和下肢截肢的主要原因，其临床特征是高血糖、胰岛素抵抗(IR)和胰岛β细胞功能衰竭。在过去几年里，大量研究强调了肠道微生物群失调与T2DM及其并发症之间错综复杂的关系，迄今为止，该领域的已知文献暗示了肠道菌群在糖尿病微血管并发症的发生和演变中具有重要作用。在这篇综述中，我们讨论了肠道菌群与已知的糖尿病微血管并发症(视网膜病变、神经病变和肾病)之间的最新知识及其在糖尿病管理中的应用。
Abstract: Type 2 diabetes mellitus (T2DM) is still one of the most important problems threatening human health and economic burden. The prevalence and incidence rate of disease is increasing. Diabetes is also the leading cause of blindness, renal failure, heart attack, stroke and lower limb amputation. Its clinical features are hyperglycemia, insulin resistance (IR) and pancreatic β cell failure. In the past few years, numerous studies have highlighted the perplexing relationship between intestinal microbiota imbalance and T2DM and its complications. So far, the known literature in this field suggests that intestinal flora plays an important role in the occurrence and evolution of diabetic microangiopathy. In this review, we discussed the latest knowledge of intestinal flora and known diabetic microvascular complications (retinopathy, neuropathy and nephropathy) and their appli-cation in diabetes management.
文章引用：马明福, 陈映存, 王丽, 丁娟, 张世清, 李玉英. 肠道菌群与2型糖尿病微血管病变的研究进展[J]. 临床医学进展, 2022, 12(6): 5299-5303. https://doi.org/10.12677/ACM.2022.126768

参考文献

[1] Larsen, N., Vogensen, F.K., Van Den Berg, F.W.J., et al. (2010) Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults. PLoS One, 5, e9085. [Google Scholar] [CrossRef] [PubMed]
[2] Yang, Q., Lin, S.L., Kwok, M.K., et al. (2018) The Roles of 27 Genera of Human Gut Microbiota in Ischemic Heart Disease, Type 2 Diabetes Mellitus, and Their Risk Factors: A Mendelian Randomization Study. American Journal of Epidemiolo-gy, 187, 1916-1922. [Google Scholar] [CrossRef] [PubMed]
[3] Gurung, M., Li, Z., You, H., et al. (2020) Role of Gut Microbiota in Type 2 Diabetes Pathophysiology. eBioMedicine, 51, 102590. [Google Scholar] [CrossRef] [PubMed]
[4] Sedighi, M., Razavi, S., Navab-Moghadam, F., et al. (2017) Comparison of Gut Microbiota in Adult Patients with Type 2 Diabetes and Healthy Individuals. Microbial Pathogenesis, 111, 362-369. [Google Scholar] [CrossRef] [PubMed]
[5] Ahmad, A., Yang, W., Chen, G., et al. (2019) Analysis of Gut Microbiota of Obese Individuals with Type 2 Diabetes and Healthy Individuals. PLoS One, 14, e0226372. [Google Scholar] [CrossRef] [PubMed]
[6] Alicic, R.Z., Rooney, M.T. and Tuttle, K.R. (2017) Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clinical Journal of the American Society of Nephrology, 12, 2032-2045. [Google Scholar] [CrossRef] 
[7] Miranda-Díaz, A.G., Pazarín-Villaseñor, L., Yanows-ky-Escatell, F.G., et al. (2016) Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease. Journal of Diabetes Research, 2016, Article ID: 7047238. [Google Scholar] [CrossRef] [PubMed]
[8] Urushihara, M. and Kagami, S. (2017) Role of the Intrarenal Ren-in-Angiotensin System in the Progression of Renal Disease. Pediatric Nephrology, 32, 1471-1479. [Google Scholar] [CrossRef] [PubMed]
[9] Ramezani, A., Massy, Z.A., Meijers, B., et al. (2016) Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target. American Journal of Kidney Diseases, 67, 483-498. [Google Scholar] [CrossRef] [PubMed]
[10] Vaziri, N.D., Wong, J., Pahl, M., et al. (2013) Chronic Kidney Disease Alters Intestinal Microbial Flora. Kidney International, 83, 308-315. [Google Scholar] [CrossRef] [PubMed]
[11] Fiaccadori, E., Cosola, C. and Sabatino, A. (2020) Targeting the Gut for Early Diagnosis, Prevention, and Cure of Diabetic Kidney Disease: Is the Phenyl Sulfate Story Another Step Forward? American Journal of Kidney Diseases, 75, 144-147. [Google Scholar] [CrossRef] [PubMed]
[12] Lu, C., Hu, Z., Wang, R., et al. (2020) Gut Microbiota Dysbiosis-Induced Activation of the Intrarenal Renin-Angiotensin System Is In-volved in Kidney Injuries in Rat Diabetic Nephropathy. Acta Pharmacologica Sinica, 41, 1111-1118. [Google Scholar] [CrossRef] [PubMed]
[13] Hu, Z.B., Lu, J., Chen, P.P., et al. (2020) Dysbiosis of Intestinal Microbiota Mediates Tubulointerstitial Injury in Diabetic Nephropathy via the Disruption of Cholesterol Homeostasis. Theranostics, 10, 2803. [Google Scholar] [CrossRef] [PubMed]
[14] Sabatino, A., Regolisti, G., Cosola, C., et al. (2017) Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease. Current Diabetes Reports, 17, Article No. 16. [Google Scholar] [CrossRef] [PubMed]
[15] Barrios, C., Beaumont, M., Pallister, T., et al. (2015) Gut-Microbiota-Metabolite Axis in Early Renal Function Decline. PLoS One, 10, e0134311. [Google Scholar] [CrossRef] [PubMed]
[16] Wen, X., Miao, L., Deng, Y., et al. (2017) The Influence of Age and Sex on Ocular Surface Microbiota in Healthy Adults. Investigative Ophthalmology & Visual Science, 58, 6030-6037. [Google Scholar] [CrossRef] [PubMed]
[17] Ham, B., Hwang, H.B., Jung, S.H., et al. (2018) Distribution and Di-versity of Ocular Microbial Communities in Diabetic Patients Compared with Healthy Subjects. Current Eye Research, 43, 314-324. [Google Scholar] [CrossRef] [PubMed]
[18] St. Leger, A.J. and Caspi, R.R. (2018) Visions of Eye Commensals: The Known and the Unknown about How the Microbiome Affects Eye Disease. BioEssays, 40, 1800046. [Google Scholar] [CrossRef] [PubMed]
[19] Beli, E., Yan, Y., Moldovan, L., et al. (2018) Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice. Diabetes, 67, 1867-1879. [Google Scholar] [CrossRef] [PubMed]
[20] Haluzík, M. and Mráz, M. (2018) Intermittent Fasting and Prevention of Diabetic Retinopathy: Where Do We Go from Here? Diabetes, 67, 1745-1747. [Google Scholar] [CrossRef] [PubMed]
[21] Rowan, S. and Taylor, A. (2018) The Role of Microbiota in Retinal Dis-ease. In: Ash, J., Anderson, R., LaVail, M., Bowes Rickman, C., Hollyfield, J. and Grimm, C., Eds., Retinal Degenera-tive Diseases, Advances in Experimental Medicine and Biology, Vol. 1074, Springer, Cham, 429-435. [Google Scholar] [CrossRef] [PubMed]
[22] Hicks, C.W. and Selvin, E. (2019) Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes. Current Diabetes Reports, 19, Article No. 86. [Google Scholar] [CrossRef] [PubMed]
[23] Grasset, E. and Burcelin, R. (2019) The Gut Microbiota to the Brain Axis in the Metabolic Control. Reviews in Endocrine and Metabolic Disorders, 20, 427-438. [Google Scholar] [CrossRef] [PubMed]
[24] Chandrasekharan, B., Anitha, M., Blatt, R., et al. (2011) Colonic Motor Dysfunction in Human Diabetes Is Associated with Enteric Neuronal Loss and Increased Oxidative Stress. Neu-rogastroenterology & Motility, 23, 131-e26. [Google Scholar] [CrossRef] [PubMed]
[25] Reichardt, F., Chassaing, B., Nezami, B.G., et al. (2017) Western Diet Induces Colonic Nitrergic Myenteric Neuropathy and Dysmotility in Mice via Saturated Fatty Acid- and Lipopolysaccharide-Induced TLR4 Signalling. The Journal of Physiology, 595, 1831-1846. [Google Scholar] [CrossRef] 
[26] Grenham, S., Clarke, G., Cryan, J.F., et al. (2011) Brain-Gut-Microbe Communication in Health and Disease. Frontiers in Physiology, 2, 94. [Google Scholar] [CrossRef] [PubMed]
[27] Nyavor, Y., Brands, C.R., May, G., et al. (2020) High-Fat Di-et-Induced Alterations to Gut Microbiota and Gut-Derived Lipoteichoic Acid Contributes to the Development of Enteric Neuropathy. Neurogastroenterology & Motility, 32, e13838. [Google Scholar] [CrossRef] [PubMed]

为你推荐